Latest news
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances MS Imaging Study with Encouraging Preliminary Results - TradingViewTradingView · Mon, 03 Aug 2026 17:15:20 GMTTrace Biosciences Raises Strategic Investment From Axogen - Pulse 2.0Pulse 2.0 · Fri, 31 Jul 2026 16:28:28 GMTTrace secures funding from Axogen for nerve imaging technology - Medical Device NetworkMedical Device Network · Thu, 30 Jul 2026 14:40:46 GMTNerve Trace imaging begins Phase I trial with Axogen backing - Stock TitanStock Titan · Wed, 29 Jul 2026 11:10:00 GMTTrace Biosciences Secures Strategic Investment From Axogen to Advance Nerve Imaging Trials - citybizcitybiz · Wed, 29 Jul 2026 07:00:00 GMTTrace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology - PR NewswirePR Newswire · Wed, 29 Jul 2026 07:00:00 GMT